On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013
Inmaculada Roldán(Hospital Universitario La Paz), Gustavo C. Rodríguez-Roca, Manuel Anguita, Juan Jorge González-Armengol(Universidad Complutense de Madrid), Jaime Masjuán(Universidad de Alcalá), Vicente Vicente(Centro Regional de Hemodonación), Andrés Íñiguez(University Hospital Complex Of Vigo), Juan M. Ruiz-Nodar, Francisco Marı́n(Instituto Murciano de Investigación Biosanitaria), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares), Luis Rodrı́guez Padial(Complejo Hospitalario Universitario de Toledo), Emilio Casariego-Vales, Vanessa Roldán(Hospital Universitario Virgen de la Arrixaca), J.L. Llisterri-Caro, José Mateo, Antonio Tello-Montoliu, José Polo García, Blanca Coll-Vinent i Puig, Jaime Gállego Culleré, Alfonso Marín-Martínez, Lina Badimón(Universitat de Vic - Universitat Central de Catalunya)
Cited by 28
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k